Academy Of Managed Care Pharmacy
lobbying client · lobbying firm
Academy Of Managed Care Pharmacy's federal footprint — reported lobbying spend and, where matched, federal money received. Figures are as reported to the U.S. Senate (LDA) and USAspending.
Reported country: 🇺🇸 United States
Lobbying over time
| FY | Lobbying spend (as client) | Lobbying billed / handled (as firm) |
|---|---|---|
| 2022 | $590,000 | $390,000 |
| 2023 | $771,000 | $531,000 |
| 2024 | $1,080,000 | $800,000 |
| 2025 | $930,000 | $610,000 |
| 2026 | $320,000 | $320,000 |
Two figures: what Academy Of Managed Care Pharmacy reported spending on its own lobbying (as a client) and what it billed or handled for the clients it represents (as a firm — revenue, not its own spend). For a self-filer these overlap.
Firms hired
- Tiber Creek Group $1,040,000 · 16 filings
Registrants that filed lobbying on behalf of Academy Of Managed Care Pharmacy.
Clients represented
Self-filed — Academy Of Managed Care Pharmacy registers and lobbies on its own behalf, with no separate outside clients.
Issues
| Issue area | Lobbied | Worked |
|---|---|---|
| Medicare/Medicaid | 18 | 18 |
| Pharmacy | 18 | 18 |
| Health Issues | 16 | — |
Issue areas across Academy Of Managed Care Pharmacy's filings, by activity count — as the client (Lobbied) and as the registrant/firm (Worked). Linked areas open the CivicGate issue page.
What they lobbied on
Reported activity from Senate LDA
-
FY2026 Medicare/Medicaid self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act/Main Street Pharmacy Access Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2026 Pharmacy self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Health Issues as client
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid.
-
FY2025 Pharmacy self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Medicare/Medicaid self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Health Issues as client
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
-
FY2025 Medicare/Medicaid self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Pharmacy self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
Show 44 more activities
-
FY2025 Health Issues as client
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
-
FY2025 Medicare/Medicaid self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Pharmacy self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Medicare/Medicaid self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Pharmacy self-filed
Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding
-
FY2025 Health Issues as client
Issues related to managed care pharmacists, including access to digital therapeutics and value-based care in Medicaid; Issues related to H.R. 3288/S. 1702 - Access to Prescription Digital Therapeutics Act of 2025.
-
FY2024 Health Issues as client
Issues related to managed care pharmacists; S.723/H.R.1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666
-
FY2024 Health Issues as client
Issues related to managed care pharmacists; S.723/H.R.1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666/S.4204 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666 S. 4204
-
FY2024 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Health Issues as client
Issues related to managed care pharmacists; S.723/H.R.1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666
-
FY2024 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Health Issues as client
Issues related to managed care pharmacists; H.R. 1458/S.723 - Access to Prescription Digital Therapeutics Act of 2023; H.R. 2666/S. 4204 - the Medicaid VBPs for Patients (MVP).
H.R. 1458 S. 723 H.R. 2666 S. 4204
-
FY2024 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2024 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Health Issues as client
Issues related to managed care pharmacists; S. 723/H.R. 1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666
-
FY2023 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Medicare/Medicaid self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Pharmacy self-filed
Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458) - To create a benefit category under Medicare and Medicaid allowing for the coverage of prescription digital therapeutics Medicaid VBPs for Patients Act (H.R. 2666) - To codify the existing Medicaid "multiple best price" rule related to value-based purchasing arrangements for drug therapies in Medicaid programs, to expand the use of value-based arrangements to drugs covered under Medicaid administered in an inpatient setting, and to make technical changes to pharmaceutical manufacturer report requirements to CMS related to these changes. Equitable Community Access to Pharmacy Services Act (H.R. 1770) - To make permanent certain emergency authorizations from the COVID-19 public health emergency related to pharmacist-provided care for COVID-19, RSV, and influenza (such as testing and immunization) and to allow reimbursement for these services under Medicare Part B. Also to automatically implement these authorizations for future public health emergencies declared under either the Public Health Service Act or the PREP Act.
S. 723 H.R. 1458 H.R. 2666 H.R. 1770
-
FY2023 Health Issues as client
Issues related to managed care pharmacists; S. 723/H.R. 1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666
-
FY2023 Health Issues as client
Issues related to managed care pharmacists; S. 723/H.R. 1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R. 2666 - the Medicaid VBPs for Patients (MVP).
S. 723 H.R. 1458 H.R. 2666
-
FY2023 Health Issues as client
Issues related to managed care pharmacists; Access to Prescription Digital Therapeutics Act of 2023 (S. 723/H.R. 1458). Equitable Community Access to Pharmacist Services (ECAPS) Act of 2023. Issues related to MedPAC.
S. 723 H.R. 1458
-
FY2022 Medicare/Medicaid self-filed
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
S. 1909 S. 1362 S. 2416
-
FY2022 Pharmacy self-filed
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. H.R. 7008 - Pre-approval information exchange act of 2022 - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products H.R. 7667 - PDUFA Reauthorization - lobbying for the inclusion of HR 7008 in HR 7667 and passage.
H.R. 7008 S. 1909 S. 1362 S. 2416 H.R. 7667
-
FY2022 Health Issues as client
Issues related to managed care pharmacists; S. 2416 - NOVEL Act of 2021; Issues related to the development and utilization of digital therapeutics; S. 3791/H.R. 7051 - Access to Prescription Digital Therapeutics Act of 2022; 21st Century CURES Act 2.0 discussion draft; and H.R. 7008 - Pre-approval Information Exchange (PIE) Act of 2022. Section 810 in the Food and Drug Amendments of 2022 (H.R. 7667) and in Consolidated Appropriations Act, 2023 (PL 117-328).
S. 2416 S. 3791 H.R. 7051 H.R. 7008 H.R. 7667
-
FY2022 Health Issues as client
Issues related to managed care pharmacists; S. 2416 - NOVEL Act of 2021; Issues related to the development and utilization of digital therapeutics; S. 3791/H.R. 7051 - Access to Prescription Digital Therapeutics Act of 2022; 21st Century CURES Act 2.0 discussion draft; and H.R. 7008 - Pre-approval Information Exchange (PIE) Act of 2022.
S. 2416 S. 3791 H.R. 7051 H.R. 7008
-
FY2022 Medicare/Medicaid self-filed
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
S. 1909 S. 1362 S. 2416
-
FY2022 Pharmacy self-filed
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
S. 1909 S. 1362 S. 2416
-
FY2022 Health Issues as client
Issues related to managed care pharmacists; S. 2416 - NOVEL Act of 2021; Issues related to the development and utilization of digital therapeutics; S. 3791/H.R. 7051 - Access to Prescription Digital Therapeutics Act of 2022; 21st Century CURES Act 2.0 discussion draft; and H.R. 7008 - Pre-approval Information Exchange (PIE) Act of 2022.
S. 2416 S. 3791 H.R. 7051 H.R. 7008
-
FY2022 Health Issues as client
Issues related to managed care pharmacists; S. 2416 - NOVEL Act of 2021; Issues related to the development and utilization of digital therapeutics; S. 3791/H.R. 7051 - Access to Prescription Digital Therapeutics Act of 2022; 21st Century CURES Act 2.0 discussion draft; and H.R. 7008 - Pre-approval Information Exchange (PIE) Act of 2022. Section 810 in the Food and Drug Amendments of 2022 (H.R. 7667).
S. 2416 S. 3791 H.R. 7051 H.R. 7008 H.R. 7667
-
FY2022 Pharmacy self-filed
Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. HR 7008/HR 7667/HR 9297/HR 2617 S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S. 3791/HR 7051 - Access to Prescription Digital Therapeutics Act of 2022 - to create a benefit category in Medicare and Medicaid for prescription digital therapeutics HR 7213 - Equitable Community Access to Pharmacy Services Act of 2022 - to reimburse certain COVID-19 care services provided by pharmacists under Medicare Part B
S. 1909 S. 1362 S. 3791
-
FY2022 Medicare/Medicaid self-filed
Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. HR 7008/HR 7667/HR 9297/HR 2617 S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S. 3791/HR 7051 - Access to Prescription Digital Therapeutics Act of 2022 - to create a benefit category in Medicare and Medicaid for prescription digital therapeutics HR 7213 - Equitable Community Access to Pharmacy Services Act of 2022 - to reimburse certain COVID-19 care services provided by pharmacists under Medicare Part B
S. 1909 S. 1362 S. 3791
-
FY2022 Medicare/Medicaid self-filed
HR 1868 - To prevent across-the-board direct spending cuts, and for other purposes. The bill continues to exempt Medicare from sequestration until December 31, 2021. Cures 2.0 - Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products
S. 1909 S. 1362 S. 2416
-
FY2022 Pharmacy self-filed
Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. H.R. 7008 - Pre-approval information exchange act of 2022 - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services S.2416 - NOVEL Act - A bill relating to the assignment of HCPCS codes and national coverage determinations for certain novel pharmaceutical products H.R. 7667 - PDUFA Reauthorization - lobbying for the inclusion of HR 7008 in HR 7667 and passage.
H.R. 7008 S. 1909 S. 1362 S. 2416 H.R. 7667
The specific issues and bills Academy Of Managed Care Pharmacy reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.